These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7493601)

  • 1. Behavioural response to SKF 38393 and quinpirole following chronic antidepressant treatment.
    Allison K; Ivanová S; Greenshaw AJ
    Eur J Pharmacol; 1995 Apr; 277(2-3):139-44. PubMed ID: 7493601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K; Smith SE; Sharp T
    J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding.
    Allison K; Paetsch PR; Baker GB; Greenshaw AJ
    Eur J Pharmacol; 1993 Nov; 249(2):125-31. PubMed ID: 8287894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioural satiety sequence.
    Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1995 Jan; 117(1):82-90. PubMed ID: 7724706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1995 Feb; 117(3):287-97. PubMed ID: 7770604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.
    Wu M; Brudzynski SM; Mogenson GJ
    Brain Res Bull; 1993; 32(4):395-8. PubMed ID: 8106125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
    Maj J; Papp M; Skuza G; Bigajska K; Zazula M
    J Neural Transm; 1989; 76(1):29-38. PubMed ID: 2565359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.
    Rimondini R; Ferré S; Giménez-Llort L; Ogren SO; Fuxe K
    Eur J Pharmacol; 1998 Apr; 347(2-3):153-8. PubMed ID: 9653875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-medial prefrontal cortex injection of quinpirole, but not SKF 38393, blocks the acute motor-stimulant response to cocaine in the rat.
    Beyer CE; Steketee JD
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):211-8. PubMed ID: 10972467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats.
    Saigusa T; Koshikawa N; Kitamura M; Mizutani K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1995 Feb; 274(1-3):213-20. PubMed ID: 7539377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogenetic quinpirole treatment induces vertical jumping activity in rats.
    Kostrzewa RM; Guo J; Kostrzewa FP
    Eur J Pharmacol; 1993 Aug; 239(1-3):183-7. PubMed ID: 7901028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.